Bausch + Lomb Corporation (NYSE:BLCO)

  • A price alert has been triggered for this video.
BLCO Weekly Chart

Old Forum Content for BLCO

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • BarryC: Im trying some $BLCO here, tight stop, low risk entry
  • BarryC: Hello Everyone and whatzzz up!! :-) This is where Im at. #Long: $ATI, $AZEK, $BILL, $BLCO, $CFLT, $EXPI, $MARA, $NVDA, $TSLA & $UPST
  • BarryC: I dumped $BLCO.... Its NOT broken, just have too much others working and not being rewarded. Will still be watching...
  • BarryC: Hello everyone! I put on a few new positions yesterday (called them out here) AND have them on tight leashes.... I went home long# $AZEK, $BILL, $BLCO, $EXPI, $MARA, $NVDA $TSLA & $UPST
  • BarryC: $BLCO worth watching!!!
  • BarryC: Some of the things Im watching: $AZEK, $BILL, $BLCO, $CFLT, $DKNG, $DT, $FND, $HUBS, $SHOP & $TREX
  • BarryC: I bot $BLCO
  • sgiseller: @BarryC $BLCO any idea if this split from $BHC ?
  • scottrades: @BarryC $BLCO Nice chart
  • BarryC: @sgiseller $BLCO $BHC Sorry, I dont...
  • BarryC: @scottrades $BLCO will be nicer IF it works :-)
  • Geewhiz: @sgiseller $BLCO $BHC May 10 2022
    LAVAL, QC and VAUGHAN, ON, May 10, 2022 /PRNewswire/ -- Bausch %2B Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb") and Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today anno ...
  • BarryC: $BLCO needs some volume to go....
  • BarryC: Two stocks I like the charts: $BLCO & AZEK
  • Henry: @BarryC $BLCO $AZEC nice charts Barry
  • joelsg1: $BLCO Crushed today on drug patent ruling against parent $BHC, putting spinoff in severe jeopardy. Beneficiaries include the other contact lens makers, $JNJ, $ALC and $COO, still my largest pos. even after major trimming, due for run into E 8/31 ( after which expecting it to fall as FX headwinds disappoint). Always sell otm covered calls, but have to wait until closer to E for market demand.
  • Docoof: @joelsg1 $BLCO $BHC $JNJ $ALC $COO Check out one you once mentioned after seeing it widely used at SpaceX in a video: $URI. —And feel free to comment. Currently—np.
  • joelsg1: @Docoof $BLCO $BHC $JNJ $ALC $COO $URI Not sure that was me, but a construction play that our dear departed but still living @bRobert setup the short on 1 month ago and well before that. Still under the 200d and gapped above the 20w today. So if this is a change in character, might pb to 20w or even down to 50d and then reassess. Np.
  • Docoof: @joelsg1 $BLCO $BHC $JNJ $ALC $COO $URI Thank you for the feedback and, in return, the incriminating evidence: “Agree, fantastic. Feel I have better insight into his management and production style, and thought processes, and think I want to do dd on $URI. Thanks” 2/10/2022 ;)
  • joelsg1: @Docoof $BLCO $BHC $JNJ $ALC $COO $URI Yeah, but I didn't buy it.
  • Docoof: @joelsg1 $BLCO $BHC $JNJ $ALC $COO $URI I know, but you’re like EF Hutton: when you post, people listen.
  • joelsg1: @Docoof $BLCO $BHC $JNJ $ALC $COO $URI Uh oh, they're defunct, and as I recall a bunch of crooks with a TV commercial.
  • BocaRick: $BLCO $BHC IPO today open up 6%, but IPO 18 price was below 22-24 estimated IPO price. np
Visit the Trading Forum to join in the discussion.
Stock Price $USD 14.32
Change 2.51%
Volume 1,755,750

Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries.

Request Video of BLCO
Already a member? Sign in here.

Earnings

  • July 30th, 2025 - 2025 Q2 Earnings
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 14 day FREE membership. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 14 day, no questions asked, 100% money back guarantee!